echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Hongri Pharmaceutical: Rocuronium Bromide Injection Obtained Drug Registration Approval

    Hongri Pharmaceutical: Rocuronium Bromide Injection Obtained Drug Registration Approval

    • Last Update: 2022-01-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit

    On December 9, Hongri Pharmaceutical issued an announcement stating that the company had recently received a drug registration approval for rocuronium injection (2.
    5ml:25mg, 5ml:50mg) issued by the State Food and Drug Administration

    The drug is an auxiliary drug for general anesthesia, used for tracheal intubation during conventional induction anesthesia, and to maintain intraoperative skeletal muscle neuromuscular block


    Rocuronium bromide injection was developed by ORGANON and was launched in the United States in 1994.
    The imported rocuronium injection was approved for marketing in China in 2000.
    There are two specifications: 2.
    5ml:25mg and 5ml:50mg

    So far, rocuronium has been widely used worldwide


    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.